AKT1 and breast carcinoma: Radiation also induces the activation of the PI3K/AKT signaling pathway in breast cancers and targeting this pathway by the dual PI3K/mTOR inhibitor NVP-BEZ235 sensitizes the MDA-MB231 and MCF7 breast cancer cells to IR [57].